These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3315450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I, Podrouzková B, Kocourková J, Kubesová H, Spác J, Nĕmcová H, Blaha M.
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O, Polívková H.
    Cor Vasa; 1987 Jun; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
    Hauger-Klevene JH, Balossi EC, Scornavacchi JC.
    Cor Vasa; 1987 Jun; 29(4 Suppl 1):17-22. PubMed ID: 3119290
    [Abstract] [Full Text] [Related]

  • 14. [A new antihypertensive agent used in a clinical setting].
    Wetzels E, Raschig A, Kaiser HJ.
    Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA, Cohen AA, Sabaris RP, Burucúa JE.
    Clin Ther; 1984 Sep 12; 6(3):325-34. PubMed ID: 6373009
    [Abstract] [Full Text] [Related]

  • 17. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
    Schäfer N, Knaup G.
    MMW Munch Med Wochenschr; 1982 Mar 12; 124(10):249-52. PubMed ID: 6806612
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ, Laszt A, Paran E, Ben Ari J, Goren Y, Modan M.
    Neth J Med; 1987 Aug 12; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.